These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A Systematic Review on the Role of Natural Products in Modulating the Pathways in Alzheimer's Disease. Auti ST; Kulkarni YA Int J Vitam Nutr Res; 2017 Mar; 87(1-2):99-116. PubMed ID: 30010515 [No Abstract] [Full Text] [Related]
5. Natural compounds against Alzheimer's disease: molecular recognition of Aβ1-42 peptide by Salvia sclareoides extract and its major component, rosmarinic acid, as investigated by NMR. Airoldi C; Sironi E; Dias C; Marcelo F; Martins A; Rauter AP; Nicotra F; Jimenez-Barbero J Chem Asian J; 2013 Mar; 8(3):596-602. PubMed ID: 23303581 [TBL] [Abstract][Full Text] [Related]
6. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters. Matsuzaki K Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558 [TBL] [Abstract][Full Text] [Related]
7. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG; Nowick JS Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987 [TBL] [Abstract][Full Text] [Related]
8. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation. Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297 [TBL] [Abstract][Full Text] [Related]
10. High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease. Sahoo BR; Cox SJ; Ramamoorthy A Chem Commun (Camb); 2020 Apr; 56(34):4627-4639. PubMed ID: 32300761 [TBL] [Abstract][Full Text] [Related]
11. Study on the inter- and intra-peptide salt-bridge mechanism of Aβ23-28 oligomer interaction with small molecules: QM/MM method. Boopathi S; Kolandaivel P Mol Biosyst; 2015 Jul; 11(7):2031-41. PubMed ID: 25973904 [TBL] [Abstract][Full Text] [Related]
13. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease. Behl T; Kaur I; Fratila O; Brata R; Bungau S Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199 [TBL] [Abstract][Full Text] [Related]
14. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Takahashi T; Mihara H Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396 [TBL] [Abstract][Full Text] [Related]
15. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide. Drew SC; Barnham KJ Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485 [TBL] [Abstract][Full Text] [Related]